Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial [Yahoo! Finance]
Aethlon Medical, Inc. (AEMD)
NASDAQ:AMEX Investor Relations:
ir.aethlonmedical.com
Company Research
Source: Yahoo! Finance
SAN DIEGO Sept. 16, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced that the Cancer Clinical Trial Unit at Royal Adelaide Hospital was activated on September 10, 2024 to begin screening and enrolling patients in its safety, feasibility and dose-finding clinical trial of the Hemopurifier® in patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® (pembrolizumab) or Opdivo® (nivolumab) (AEMD-2022-06 Hemopurifier Study). The trial will be conducted by Prof. Michael Brown and his staff at the Cancer Clinical Trials Unit, CALHN, Royal Adelaide Hospital in Australia The activation follows the previously announced approval by the Human Research Ethics Committee at Central Adelaide Local Health Network on June 13, 2024 , and the Research Governance office at Royal Adelaide Hospit
Show less
Read more
Impact Snapshot
Event Time:
AEMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AEMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AEMD alerts
High impacting Aethlon Medical, Inc. news events
Weekly update
A roundup of the hottest topics
AEMD
News
- Aethlon Medical, Inc. (NASDAQ: AEMD) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in IndiaPR Newswire
- Aethlon Medical to Present at Virtual Investor Conferences in September [Yahoo! Finance]Yahoo! Finance
- Aethlon Medical to Present at Virtual Investor Conferences in SeptemberPR Newswire
- Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer TrialPR Newswire
AEMD
Earnings
- 8/14/24 - Beat
AEMD
Sec Filings
- 9/19/24 - Form 8-K
- 8/15/24 - Form ARS
- 8/15/24 - Form DEFA14A
- AEMD's page on the SEC website